ConductScience.org, home

Paper326384

The CMF program for operable breast cancer with positive axillary nodes. Updated analysis on the disease-free interval, site of relapse and drug tolerance.

Bonadonna G and 4 others. Cancer, 1977. Cited by 265 papers, by iCite.

Cite this record

ConductScience Library. The CMF program for operable breast cancer with positive axillary nodes. Updated analysis on the disease-free interval, site of relapse and drug tolerance. Papers, record 326384. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/326384

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The CMF program for operable breast cancer with positive axillary nodes. Updated analysis on the disease-free interval, site of relapse and drug tolerance.
PubMed
Journal
Cancer
PubMed
Year
1977
PubMed
Publication types
Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
265
iCite
Relative citation ratio, by iCite
12.1
iCite
Revised in PubMed
2019-06-19
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Bonadonna GG
2Rossi AA
3Valagussa PP
4Banfi AA
5Veronesi UU

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Breast NeoplasmsMajor topic
CyclophosphamideMajor topic
FluorouracilMajor topic
MethotrexateMajor topic
Amenorrhea
Clinical Trials as Topic
Drug Therapy, Combination
Female
Humans
Leukopenia
Lymphatic Metastasis
Mastectomy
Menopause
Middle Aged
Thrombocytopenia

Source PubMed

Download CSV of topics

Cited by40

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 265 citations.

PMIDTitleJournalYearIn PapersSource
26123412Partial axillary lymph node dissection inferior to the intercostobrachial nerves complements sentinel node biopsy in patients with clinically node-negative breast cancer.BMC Surg2015https://conductscience.org/library/papers/26123412PubMed
23139057Patterns and predictors of breast cancer chemotherapy use in Kaiser Permanente Northern California, 2004-2007.Breast Cancer Res Treat2013https://conductscience.org/library/papers/23139057PubMed
21274246Management of breast cancer: what do I tell the patient?Can Fam Physician1986https://conductscience.org/library/papers/21274246PubMed
20595533Meta-analysis as a manifestation of 'bondförnuft' ('peasant sense').J R Soc Med2010https://conductscience.org/library/papers/20595533PubMed
18629447Types of bone metastases in women with breast cancer undergoing systemic treatments.Radiol Med2008https://conductscience.org/library/papers/18629447PubMed
17295093
Clinical and radiological evaluation of patients with lytic, mixed and sclerotic bone metastases from solid tumors: is there a correlation between clinical status of patients and type of bone metastases?
Clin Exp Metastasis2007https://conductscience.org/library/papers/17295093PubMed
7779726Reduced mitogenic stimulation of peripheral blood mononuclear cells as a prognostic parameter for the course of breast cancer: a prospective longitudinal study.Br J Cancer1995https://conductscience.org/library/papers/7779726PubMed
7397944Antitumor drug toxicity in tumor-free and tumor-bearing mice.Cancer Chemother Pharmacol1980https://conductscience.org/library/papers/7397944PubMed
7362189Primary treatment of breast cancer by modified radical mastectomy, radiotherapy, and chemotherapy.Ann R Coll Surg Engl1980https://conductscience.org/library/papers/7362189PubMed
7265817Pathobiology of breast cancer: hypothesis of biological predetermination and long-term survival.Klin Wochenschr1981https://conductscience.org/library/papers/7265817PubMed
7228880The effect of chemotherapy on occult metastases after surgical removal of a non-immunogenic mouse carcinoma.J Cancer Res Clin Oncol1980https://conductscience.org/library/papers/7228880PubMed
7041939Preliminary results of primary systemic chemotherapy in association with surgery or radiotherapy in rapidly progressing breast cancer.Br J Cancer1982https://conductscience.org/library/papers/7041939PubMed
7014886Adjuvant chemotherapy and immunotherapy for colorectal cancer: preliminary communication.J R Soc Med1980https://conductscience.org/library/papers/7014886PubMed
7004560Adjuvant chemotherapy for breast cancer: side effects and quality of life.Br Med J1980https://conductscience.org/library/papers/7004560PubMed
6788145Breast cancer: a case for conservation.Br Med J (Clin Res Ed)1981https://conductscience.org/library/papers/6788145PubMed
6784849Multimodal treatment in operable breast cancer: five-year results of the CMF programme.Br Med J (Clin Res Ed)1981https://conductscience.org/library/papers/6784849PubMed
6772333Surgery plus adjuvant chemotherapy--a review of therapeutic implications. I. Breast cancer.Cancer Chemother Pharmacol1980https://conductscience.org/library/papers/6772333PubMed
6736112Estrogen receptor status and adjuvant polychemotherapy or antiestrogen therapy in patients with high-risk breast cancer.J Cancer Res Clin Oncol1984https://conductscience.org/library/papers/6736112PubMed
6708398Adjuvant chemotherapy of breast cancer: hope--reality--hazard?Klin Wochenschr1984https://conductscience.org/library/papers/6708398PubMed
3983039Controversies in the medical management of breast cancer.Postgrad Med J1985https://conductscience.org/library/papers/3983039PubMed

See all 40 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/326384

GET https://conductscience.org/api/papers/v1/326384/cited_by?page=2